Medable

09/02/2025

Clinical development is getting more complex, and the white space between trial phases is stretching longer. It's time for change! 💯

Agentic AI offers a smarter path forward, enabling teams to do more with less by augmenting human effort and automating routine work, so people can focus where they’re needed most.

Join Medable’s experts on this upcoming live session as they explore low-risk, high-impact use cases for bringing agentic AI into clinical operations today.

The speakers will walk through scenarios well-suited for agents, including protocol automation, instrument generation, translations, and site monitoring.

👉 Secure your spot here to kickstart your AI journey: https://webinars.endpoints.news/not-just-a-tool-how-ai-agents-become-trial-teammates/
________

08/29/2025

With Medable AI, what once took weeks now takes minutes.💥

🟣 Easily transform your PDFs into digital instruments with a simple prompt or upload.
🟣 Go global with wide-reaching confidence and local precision, instantly translating your new assets.
🟣 Experience simple, streamlined study testing like never before.

The future will see you now; learn more here: https://www.medable.com/platform/ai
________

08/28/2025

Curious about using AI agents in clinical trials but not sure where to begin? You’re not alone! While the potential is clear, many sponsors and CROs find the first step overwhelming.

Join Medable’s AI leaders as they explore low-risk, high-impact use cases for bringing agentic AI into clinical operations today. The speakers will walk through scenarios well-suited for agents, including protocol automation, instrument generation, translations, and site monitoring.

Secure your spot here to kickstart your AI journey: https://webinars.endpoints.news/not-just-a-tool-how-ai-agents-become-trial-teammates/
________

08/26/2025

Tomorrow! 📢 Join us at Clinical Leader's Virtual Solution Expo for a live demo of our AI-powered eCOA platform! Rana Khan will showcase how automation streamlines study configuration, multilingual localization, and validation, enhancing quality and completing weeks of manual effort in just minutes. 💥

👉 Register here: https://event.on24.com/wcc/r/5007345/467961ECFD81169DC3E963D3A75E7A98
________

08/20/2025

Clinical trials are more complex than ever, but building and launching global studies doesn’t have to be. Join us at Clinical Leader's Solution Expo for a live demo of our AI-powered eCOA platform to learn more!
You'll see how automation streamlines study configuration, multilingual localization, and validation, enhancing quality and completing weeks of manual effort in just minutes. 💥

👉 Secure your spot here: https://event.on24.com/wcc/r/5007345/467961ECFD81169DC3E963D3A75E7A98
________

08/19/2025

In a rapidly changing R&D landscape, leaders at Takeda, Novartis, Sanofi, Daiichi Sankyo, and Medable share firsthand insights into how AI is reshaping clinical trial operations. 🔬

This exclusive white paper explores how forward-thinking organizations are evolving study design and ex*****on to meet the demands of speed, precision, and patient-centricity across their entire portfolio.

👉 Unlock the power of AI here: https://www.medable.com/knowledge-center/long-form-rewriting-the-future-of-clinical-trials-ai-agility-and-the-portfolio-first-mandate?utm_source=linkedin&utm_medium=organic&utm_campaign=&utm_content=
________

08/18/2025

What if clinical trial startups could happen in days, not weeks?
With AI-powered translations, that vision is moving closer to reality. By breaking the long-standing translation bottleneck, sponsors can launch global studies faster, reduce costs, and deliver new treatments to patients sooner.

👉 Here's how: https://www.medable.com/knowledge-center/blog-from-bottlenecks-to-breakthroughs-how-ai-is-transforming-translation-timelines
________

08/13/2025

The adoption of agentic AI signals more than just a technological upgrade; it heralds a new era of human-machine collaboration in clinical research, where intelligent systems act as strategic partners, accelerating progress while upholding the rigor and empathy that define responsible science. 🔬

👉 Learn more from AI leaders, including Medable CEO Dr. Michelle Longmire, about the use cases for agentic AI in drug development: https://globalforum.diaglobal.org/issue/august-2025/next-steps-in-artificial-intelligence-agentic-ai/
________

Agentic AI represents the next generation of AI in business.

08/12/2025

43% faster translation timelines. 55% shorter review cycles. 25% cost savings. 🚀

By shattering long-standing bottlenecks, AI is making the translation process for study components faster and more efficient. In turn, this accelerates the delivery of life-changing treatments to patients worldwide.

As we move forward, this innovative approach is more than an incremental improvement. Instead, it moves Medable’s vision of a one-day trial startup one step closer towards reality.

👉 Learn about the power of an AI-enabled workflow here: https://www.medable.com/knowledge-center/long-formcase-study-removing-translation-bottlenecks-with-ai
______

08/11/2025

Our CRO Partner Program delivers business-winning tools to those who don't have time to waste.

Generate study-specific quotes in 30 seconds with our self-serve pricing calculator.

Find out how to unlock our partner incentives by sending this account a DM! 📥

08/06/2025

🎤 Xiong Liu, Director of Data Science and AI at Novartis, shared his thoughts on the evolving role of AI in modernizing clinical trials during a recent podcast episode brought to you by Medable.

He specifically covered how life sciences teams are leveraging AI to streamline data workflows, accelerate study readiness, and maintain regulatory compliance in both decentralized and traditional models. Additionally, Xiong offered insights into the growing importance of integrating structured and unstructured data across trial systems—from clinical notes to imaging and lab results.

👉 Listen here: https://podcast.emerj.com/the-evolving-role-of-ai-in-modernizing-clinical-trials-with-xiong-liu-of-novartis
________

08/05/2025

Every cell and gene therapy (CGT) clinical trial involves patients hoping for a better future, not just for themselves, but for the next generation.

However, the path to progress in this field of research is steep. The structure of today’s CGT studies places an immense burden on participants, with long-term follow-up demands, high costs, and often hundreds of miles of travel.

To truly honor the sacrifices patients make, the industry must rethink how trials are designed—infusing them with flexibility, digital convenience, and compassionate infrastructure.

🔗 Read from Dr. Pamela Tenaerts how the future of CGT depends on it:
https://www.pharmalive.com/for-our-childrens-sake-the-critical-mission-of-enabling-more-flexible-clinical-trial-designs-for-cell-and-gene-therapies/
________

Patients choose to participate in clinical trials for various reasons – to help advance medical science, to help the life sciences community find treatments faster, to help themselves find a chance at survival. However, one of the most compelling reasons for participating in a trial is to help our...